CSI Frankfurt

June 3-6, 2026 | Frankfurt, Germany (Forum Messe)

At CSI Frankfurt 2026, we had the opportunity to introduce the recent CE Mark approval of PULSTA CE to leading European key opinion leaders (KOLs) who had been eagerly anticipating its commercial launch. The announcement generated significant interest and positive engagement throughout the meeting.


Visitors to the exhibition booth were invited to experience the valve loading and deployment process firsthand. Many physicians commented on the intuitive design, highlighting the simplicity, efficiency, and user-friendly nature of the system.


A live case was also successfully performed on June 5. The procedure was conducted by Prof. Peter Ewert of the German Heart Center Munich, with Prof. Gi-Beom Kim serving as the proctor. Following CE Mark approval, this represented the first live PULSTA CE case performed and broadcast from a European clinical site, marking an important milestone in the product's introduction to the European market and demonstrating its clinical applicability to an international audience.